Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A forecasting approach to accelerate drug development

C A Hunt1, S Guzy, D L Weiner

  • 1University of California, San Francisco 94143-0446, USA.

Statistics in Medicine
|September 28, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On the Meaning of the Term "Symptom".

Western journal of medicine and surgery·2024
Same author

Cold and Wet a Cause of Camp Disease, and Its Modus Operandi.

Chicago medical examiner·2023
Same author

Credibility, Replicability, and Reproducibility in Simulation for Biomedicine and Clinical Applications in Neuroscience.

Frontiers in neuroinformatics·2018
Same author

Lymphatic transport of liposome-encapsulated drugs following intraperitoneal administration - effect of lipid composition.

Pharmaceutical research·2013
Same author

Engineering targeted in vivo drug delivery. I. The physiological and physicochemical principles governing opportunities and limitations.

Pharmaceutical research·2013
Same author

Stimulated emission and tunable gain from Rh(2+) ions in RbCaF(3) crystals.

Optics letters·2009
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
Same journal

Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

Statistics in medicine·2026
See all related articles

A new clinical trials Forecaster system aims to reduce drug development time and cost. This system predicts clinical study success, optimizes pharmacokinetic/pharmacodynamic (PK/PD) data, and enhances population targeting for more efficient drug development.

Area of Science:

  • Pharmacometrics
  • Clinical Pharmacology
  • Drug Development

Background:

  • Clinical drug development is costly and time-consuming.
  • Current methods often rely on extensive studies, increasing expenses.
  • There is a need for more efficient decision-support systems in drug development.

Purpose of the Study:

  • To develop a decision support system for earlier and more cost-effective clinical drug development.
  • To introduce a 'clinical trials Forecaster' prototype with enhanced predictive capabilities.
  • To improve the utilization of pharmacokinetic/pharmacodynamic (PK/PD) data for better drug development outcomes.

Main Methods:

  • Developed a system predicting clinical study success probabilities.
  • Integrated optimal utilization and prediction enhancement of PK/PD data.

Related Experiment Videos

  • Enabled projection of population-level results with reliability measures.
  • Linked initial clinical predictions to preclinical (animal) and drug class data.
  • Generated population PK/PD parameter joint density estimates for simulation.

    • Main Results:

    • The Forecaster prototype demonstrates the ability to generate statistically indistinguishable simulated data from experimental data.
    • Simulated data allows for assumption validation and inference on population targets.
    • Predictions are accompanied by a measure of reliability.
    • Demonstrated use with 22 PK/PD parameter sets for an oral analgesic.

    Conclusions:

    • The developed clinical trials Forecaster system can significantly improve the efficiency of drug development.
    • Early specification, challenge, and revision of population targets are enabled.
    • The system offers a reliable method for predicting clinical study outcomes and optimizing drug development pathways.